Activated charcoal

What it is

Activated charcoal is a carbon powder that has been processed to give it a very large surface area, and it is used in medicine as a gastrointestinal adsorbent. It binds drugs and toxins inside the gut so that less of them reaches the bloodstream. It is not itself absorbed: it passes through the gut and leaves in the stool unchanged. It binds non-polar, poorly water-soluble organic compounds well, and binds alcohols, metals such as iron and lithium, electrolytes, acids and alkalis poorly.

What the research says

The evidence for activated charcoal sits almost entirely in acute poisoning medicine, not in consumer wellness. A large systematic review that graded every study found most of the evidence was low or very low quality, and a clinical reference notes that no study has shown it improves mortality, morbidity or length of stay. The largest randomised trial ever run, in 4,632 self-poisoned patients, found no difference in death rates. Expert societies still recommend it for selected poisons. For the popular 'detox' and 'cleanse' uses there is no supporting trial evidence, and the same binding that makes it useful in overdose also means it can bind medicines, vitamins and minerals taken at the same time.

Evidence grade: Disputed.

What goes wrong

Vomiting is the most common adverse effect of activated charcoal, occurring in about one in five patients in a prospective study. (Source 1)

• Expert review, not systematic, Low certainty.
• Size: 275 patients in the cited prospective study.
• Who: emergency department patients given activated charcoal.
• How long: emesis within 2 hours of administration.
• Result: 56 of 275 (20.4%) vomited, half within 10 minutes; reported incidence across studies 6-26%.
• Funding: not stated.

They found that 56 of 275 (20.4%) patients vomited after receiving activated charcoal, with half vomiting within 10 min of initiation of activated charcoal.

Clinically significant pulmonary aspiration after multiple-dose activated charcoal was recorded in about 6 per 1,000 patients in a multi-hospital retrospective study. (Source 1)

• Expert review, not systematic, Low certainty.
• Size: retrospective series across eight tertiary care hospitals.
• Who: patients receiving two or more doses of activated charcoal.
• How long: in-hospital.
• Result: 0.6% (5.7 per 1000) met criteria for significant aspiration; all five required intubation and ventilation for 1-3 days; no deaths from aspiration in that series.
• Funding: not stated.

They found that 0.6% (5.7 per 1000) had met all their criteria for significant aspiration.

National poison surveillance data identified deaths in which aspiration of activated charcoal contributed, including two paediatric deaths attributed directly to charcoal aspiration. (Source 1)

• Expert review, not systematic, Low certainty.
• Size: TESS data 1993-2002.
• Who: poisoned patients reported to US poison centres.
• How long: 10 years of surveillance data.
• Result: seven reported deaths with charcoal aspiration as at least a contributing factor; two further paediatric deaths directly related to aspiration of charcoal.
• Funding: not stated.

described seven reported deaths in which aspiration of activated charcoal was at least a contributing factor in their deaths

Regular consumption of activated charcoal in foods and drinks risks reducing the effectiveness of medicines taken at the same time and binding vitamins and minerals. (Source 2)

• Expert review, not systematic, Very low certainty.
• Size: not applicable.
• Who: consumers of charcoal-containing foods and beverages.
• How long: regular consumption.
• Result: reduced medication effectiveness, nutrient deficiency and constipation flagged as safety concerns by the Association of Food and Drug Officials.
• Funding: not stated.

may be at risk for reduced effectiveness of routine medications, nutrient deficiencies related to activated charcoal

Activated charcoal reduces the systemic absorption of a wide range of ingested drugs, which is also why it can interfere with medicines taken alongside it. (Source 3)

• Expert review, not systematic, Low certainty.
• Size: not applicable.
• Who: not applicable.
• How long: not applicable.
• Result: decreased absorption reported for acetaminophen, aspirin, barbiturates, tricyclic antidepressants, theophylline and phenytoin; poor adsorption of alcohols, metals and electrolytes.
• Funding: not stated.

Most ingested toxins will have decreased systemic absorption in the presence of activated charcoal, including acetaminophen, aspirin, barbiturates, tricyclic antidepressants, theophylline, phenytoin, and most inorganic and organic materials.

What the evidence supports

A systematic review that screened 22,950 titles found the evidence base for activated charcoal in poisoning is large but mostly of low quality; in the clinical data it reviewed the first dose was usually given more than an hour after ingestion, and on that basis it reported a benefit beyond one hour in many scenarios. (Source 4)

• Systematic review, Low certainty.
• Size: 296 human studies, 118 animal studies and 145 in vitro studies, from 22,950 titles screened.
• Who: adults and children with acute poisoning.
• How long: databases searched from inception to 31 December 2019.
• Result: 469 of the studies (83%) were judged Low or Very Low GRADE and 90 Moderate or High; no studies on optimal dosing were found; in the reviewed clinical data the first charcoal dose was given beyond one hour in 97% (n = 1006), beyond two hours in 36% (n = 491) and beyond 12 h in 4% (n = 43)
• Funding: not stated.

In the reviewed clinical data, the time of administration of the first dose of charcoal was beyond one hour in 97% (n = 1006 individuals), beyond two hours in 36% (n = 491 individuals), and beyond 12 h in 4% (n = 43 individuals) whereas the timing of the first dose in controlled studies was within one hour of ingestion in 48% (n = 2359 individuals) and beyond two hours in 36% (n = 484) of individuals. CONCLUSIONS: This systematic review found heterogenous data. The higher GRADE data was focused on a few select poisonings, while studies that addressed patients with unknown and or mixed ingestions were hampered by low rates of clinically meaningful toxicity or death. Despite these limitations, they reported a benefit of activated charcoal beyond one hour in many clinical scenarios.

What the evidence does not support

In the largest randomised trial of multiple-dose activated charcoal, mortality was no different from no charcoal. (Source 5)

• Randomized trial, Moderate certainty.
• Size: 4,632 patients randomised; outcomes available for 4,629.
• Who: patients admitted after intentional self-poisoning (51% pesticides, 36% yellow oleander seeds) in three Sri Lankan hospitals.
• How long: six 50 g doses at 4-hour intervals; in-hospital mortality.
• Result: 97/1531 (6.3%) died with multiple-dose charcoal vs 105/1554 (6.8%) with no charcoal; adjusted odds ratio 0.96, 95% CI 0.70-1.33.
• Funding: not stated.

Mortality did not differ between the groups. 97 (6.3%) of 1531 participants in the multiple-dose group died, compared with 105 (6.8%) of 1554 in the no charcoal group (adjusted odds ratio 0.96, 95% CI 0.70-1.33).

A clinical reference states that while charcoal reduces absorption of many toxins, no study has shown it improves patient-oriented outcomes such as death or length of stay. (Source 6)

• Expert review, not systematic, Low certainty.
• Size: not applicable.
• Who: poisoned patients.
• How long: not applicable.
• Result: no demonstrated effect on mortality, morbidity or length of hospital stay.
• Funding: not stated.

no studies have demonstrated improvements in patient-oriented outcomes, such as mortality, morbidity, or length of hospital stay, with its use.

Activated charcoal is not an approved food additive in the United States despite its use as a food colourant and 'cleanse' ingredient. (Source 2)

• Expert review, not systematic, Certainty not rated.
• Size: not applicable.
• Who: not applicable.
• How long: not applicable.
• Result: not listed or recognised under sections 201(s) and 409 of the Federal Food, Drug, and Cosmetic Act; not approved as a food additive under 21 CFR Part 184.
• Funding: not stated.

activated charcoal is not currently approved as a food additive by the US Food and Drug Administration (FDA) under 21 CFR, Part 184

Where the evidence is mixed

The same systematic review rated the great majority of the included studies as low or very low quality. (Source 4)

• Systematic review, Very low certainty.
• Size: 559 studies graded.
• Who: human, animal and in vitro poisoning studies.
• How long: inception to December 2019.
• Result: Low or Very Low GRADE in 469 (83%) of the studies; Moderate or High in 90.
• Funding: not stated.

The quality was judged to have a Low or Very Low GRADE in 469 (83%) of the studies.

What official bodies say

An international expert workgroup concluded, by Delphi consensus, that activated charcoal has no role at all for several common poisons. (Source 7)

• Official position, Low certainty.
• Size: 43 poisons or poison categories appraised.
• Who: poisoned patients.
• How long: two-round modified Delphi; published 2025.
• Result: no role for arsenic, caesium, copper, ethanol, methanol, ethylene glycol, iron, lead, lithium and metformin; appropriate up to 6 h post-ingestion for many other poisons.
• Funding: not stated.

The Workgroup concluded that there is no role for activated charcoal in poisoning from arsenic, caesium, copper, ethanol, methanol, ethylene glycol, iron, lead, lithium, and metformin.

Where the research disagrees

How long after a poisoning activated charcoal is still worth giving

• The 2005 AACT-era framing reflected in current clinical references, narrative-review of position statements: An oral suspension of activated charcoal may be considered in cases of poisoning when gastrointestinal decontamination is indicated, and the clinician can administer it within 1 hour of ingestion. (Source 6)
• Clinical Toxicology Recommendations Collaborative activated charcoal workgroup, 2026, Delphi consensus recommendations built on a systematic review: The Workgroup recommends the administration of a single-dose of activated charcoal beyond the traditional 1 h post-ingestion time point in selected poisons (Source 7)

Whether multiple-dose activated charcoal should be used routinely

• Eddleston and colleagues, randomised trial in 4,632 patients, rct: We cannot recommend the routine use of multiple-dose activated charcoal in rural Asia Pacific (Source 5)
• Clinical Toxicology Recommendations Collaborative, 2026, position: Multiple-dose activated charcoal for enhanced elimination is appropriate in poisoning with carbamazepine, cardiac glycosides, colchicine, dapsone, phenobarbital, phenytoin, thallium and theophylline. (Source 7)

How much

• Reference intake: No dietary reference intake exists. Activated charcoal is not a nutrient; it is described as a gastrointestinal adsorbent used in acute oral poisoning and overdose, and it is not absorbed from the gut. (Source 8)
• Upper limit: No tolerable upper intake level or acceptable daily intake has been set. The 2021 systematic review reported that it found no studies at all on optimal dosing for single-dose or multiple-dose activated charcoal. (Source 4)
• Studied: The Sri Lankan randomised trial gave either one 50 g dose or six 50 g doses of activated charcoal at 4-hour intervals. (Source 5)
• Studied: A clinical reference describes an oral suspension of activated charcoal administered within 1 hour of ingestion when gastrointestinal decontamination is indicated in poisoning. (Source 6)

A common belief, and what the research shows

The belief: Activated charcoal 'detoxes' the body, cleansing accumulated toxins from the blood and organs.

What the research shows: Charcoal never leaves the gut, so it cannot reach toxins already in the body: a clinical reference states that 'Orally administered activated charcoal does not get absorbed through the gastrointestinal tract and remains in its unchanged form within the gut lumen.' Its consumer use is a marketing phenomenon rather than a studied one, described as gaining popularity as a food additive 'primarily for its distinctive black color in foods and beverages and its purported earthy flavor', and regulators have flagged that regular consumers 'may be at risk for reduced effectiveness of routine medications, nutrient deficiencies related to activated charcoal'.

Questions and answers

What is it?

Activated charcoal is carbon that has been treated to create an enormous internal surface area, sold as a powder, suspension or capsule. In medicine it is used as a gastrointestinal adsorbent for acute oral poisoning and overdose. It is a physical binder, not a drug that acts on the body. (Source 8)

What does it do in the body?

It works entirely inside the gut. Toxins and drugs stick to its surface so that less of them crosses into the bloodstream, and it is not absorbed itself. It binds non-polar, poorly water-soluble organic compounds best, and binds alcohols, metals, electrolytes, acids and alkalis poorly. (Source 9)

Is it good or bad for you?

It depends entirely on the setting. In hospital, for specific recent poisonings, expert societies still recommend it, though the underlying evidence is mostly low quality and the largest randomised trial found no survival benefit. Outside that setting it has no demonstrated benefit, and it carries real risks including vomiting, aspiration into the lungs and interference with medicines. (Source 6)

How do you get more of it?

In poisoning care it is given as an oral suspension or through a gastric tube, as a single 50 g dose or as repeated doses. In consumer products it appears as a black food and drink colourant and in capsules. It is not a nutrient, so there is no dietary requirement to meet. (Source 2)

If it is harmful, what reduces it?

It clears itself. Swallowed activated charcoal is not absorbed into the body and passes out unchanged in the stool, which is why stools turn black after a dose. What persists is not the charcoal but its effect on anything taken with it, such as reduced absorption of medicines. (Source 9)

Why might someone be low in it or missing it?

Does not apply. Activated charcoal is a manufactured adsorbent, not a nutrient or a resident of the body, so there is no state of being low in it or deficient. It is only present when someone has recently swallowed it, and it leaves the gut unchanged. (Source 9)

Which whole foods contain it or feed it?

No whole food naturally contains activated charcoal. It appears in food only as a deliberately added black colourant in novelty foods and drinks, and in the United States it is not an approved food additive. (Source 2)

What happens if you do not have it?

Nothing happens, because there is no requirement for it. The only consequence of not having activated charcoal is in acute poisoning, where an expert workgroup recommends it for selected poisons, and even there a randomised trial of 4,632 self-poisoned patients found no difference in deaths between those given it and those not. (Source 5)

How can you test for it?

There is no test for activated charcoal status, because it is not a body constituent. In poisoning care the decisions are clinical rather than laboratory-based: whether the airway is protected, what was swallowed and when. We found no validated test in the sources we searched. (Source 4)

We searched: Searched the 2021 GRADE-rated systematic review of activated charcoal in oral overdose, the 2026 Clinical Toxicology Recommendations Collaborative recommendations, and the StatPearls clinical monograph; none describes a test for activated charcoal in a person.

References

1. Current Opinion in Pediatrics. Activated charcoal for pediatric poisonings: the universal antidote?. 2007. Read the source
2. StatPearls, NCBI Bookshelf (NBK482294). Activated Charcoal - Indications (non-clinical and food-additive use). n.d.. Read the source
3. StatPearls, NCBI Bookshelf (NBK482294). Activated Charcoal - Mechanism of Action (adsorption spectrum). n.d.. Read the source
4. Clinical Toxicology (Philadelphia, Pa.). Systematic review on the use of activated charcoal for gastrointestinal decontamination following acute oral overdose. 2021. PMID 34424785, DOI 10.1080/15563650.2021.1961144. Read the source
5. The Lancet. Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. 2008. PMID 18280328, DOI 10.1016/S0140-6736(08)60270-6. Read the source
6. StatPearls, NCBI Bookshelf (NBK482294). Activated Charcoal - Indications (opening). n.d.. Read the source
7. Clinical Toxicology, Vol. 64, No. 6, 419-475. Recommendations from the Clinical Toxicology Recommendations Collaborative on the administration of activated charcoal in acute oral overdose. 2026. PMID 41906697, DOI 10.1080/15563650.2025.2609807. Read the source
8. StatPearls, NCBI Bookshelf (NBK482294). Activated Charcoal - Continuing Education Activity. n.d.. Read the source
9. StatPearls, NCBI Bookshelf (NBK482294). Activated Charcoal - Mechanism of Action (opening). n.d.. Read the source